Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: Results of the CEZAR study
To access this article, please choose from the options below
PII: S0021-9150(08)00846-0
doi:10.1016/j.atherosclerosis.2008.11.032
© 2009 Elsevier Ireland Ltd. All rights reserved.
